drago ... that would indeed be amazing to hear that BoM2 could begin by July of this year (first half of this year). I feel the BoM2 trial has a high likelihood of success, based on the results of BoM, and the narrow miss, and given what we learned about the best combinations/interaction SOC drugs and restacking the deck without stroke.

I haven't watched the replay, but that really suprises me since we haven't heard anything to that effect, and the assumption has been that it is ALL ABOUT Covid at the moment with the limited resources. Plus, without a BP or other large financial partner, my assumption was that financial benefits and credibility from Covid was going to drive the BoM2 study financing??

Looking forward to hearing more about this, if accurate, and if there is a possibility of conducting BoM2 that soon and prior to Covid/EUA wrap up??